Crossmark

10 Years of breakthroughs in peripheral vascular disease

Crossref DOI link: https://doi.org/10.1038/nrcardio.2014.153

Published Online: 2014-09-30

Published Print: 2014-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Creager, Mark A.
License Information

Text and Data Mining valid from 2014-09-30
More Information

Article History

First Online: 30 September 2014

Competing interests

: M.A.C. declares that he has received consulting fees from AstraZeneca and Novartis.